Decentralized Trial Technology Insights

  1. CVS Health Wants To Be Your New Clinical Research Site 7/6/2022

    CVS has been a well-regarded and recognized healthcare brand that started as a pharmacy but has since migrated into a recognized and trusted healthcare company. Now CVS is hoping to expand the relationship it has with patients by moving closer into primary care and clinical trials.

  2. Decentralized Clinical Trials: Key Considerations For Sites & PIs 6/21/2022

    As we work to harness the benefits of hybrid and DCTs, sites and investigators must have processes that allow for the acceptance of DCTs and successful implementation. As these policies are under development, the vital viewpoints of sites and PIs are largely overlooked. This article shares these vital viewpoints of sites and PIs.

  3. What Does The Future Hold For Decentralized Clinical Trials? 4/20/2022

    What can we expect to see from decentralized trials in the next three years, and what are the challenges sponsor companies will need to overcome? A webinar hosted by IBM Watson hoped to answer that question and many others.

  4. The Next Three Years Of Clinical Trials: DCTs, RWE, And Beyond 4/18/2022

    Recent years have seen unprecedented innovation in the clinical space. Precision medicine, cell and gene therapies, decentralized trials, real-world data, and the promise of artificial intelligence (AI) and machine learning (ML) are just a few of the reasons to be excited about the future of clinical research.

  5. Best Practices For Designing Patient-Centric Decentralized Clinical Trials 4/12/2022

    Decentralized clinical trials are not universally applicable to all phases of a trial and therapeutic areas. The recommendations in this article may bring decentralized and hybrid trials to a more tangible and realistic view and, in essence, make them more executable.

  6. 2021 Clinical Research Site Survey Findings: A Year In Flux 3/24/2022

    Since its inception in 2012, the Society for Clinical Research Sites (SCRS) has conducted an annual survey of clinical research site community members to derive insights, reveal trends, and ensure the site perspective is represented. This article summarizes the 2021 survey's findings.

  7. How To Turn Your Clinical Supply Chain Pandemic Learnings Into New Best Practices 3/10/2022

    Pivoting, navigating, and problem solving in real time during the pandemic has led to many real-time lessons that have evolved into adapted best practices in the global clinical supply space. This article discusses the new demand curve, packaging operations, IRT considerations, and more.

  8. Trends In Decentralized Clinical Trial Remote Monitoring For Medication Adherence 2/23/2022

    With the implementation of real-time remote monitoring technology, pharmas will be able to do more remote studies that require clinical trial patients to visit sites less frequently. This will remove the burden on patients and improve patient recruitment and retention. This article focuses on the patient medication adherence market.

  9. Patient Diversity In Clinical Studies: The Key To Advancing Precision Medicine 2/22/2022

    Until we have better inclusion of participants with diverse demographics and behaviors – and can analyze that data – we won’t know the effectiveness of a product for these patients. This article shares the barriers to patient diversity in traditional studies, the efforts that the authors' company is putting forth, and considerations to keep in mind.

  10. Explosive Investment In Virtual Trial Companies: The Latest Data 1/20/2022

    This article looks at the blossoming ecosystem and investment growth in the virtual trial space, specifically virtual trial companies that are foregoing the legacy clinical trial models and leveraging new technologies. Further, the article explores the power of the virtual trial platform and the key areas life sciences companies should consider when working with these virtual partners.